Lower urinary tract symptoms and male sexual dysfunction: The Multinational Survey of the AginG Male (MSAM-7);Troubles urinaires du bas appareil et dysfonction sexuelle masculine: L'Enquête MSAM-7 ou Enquête Multinationale de l'Homme Agé

Progres en Urologie

Volumn 14, Issue 3, 2004, Pages 332-344

  Rosen, Raymond ^a   Altwein, Jens ^b   Boyle, Peter ^c   Kirby, Roger S ^d   Lukacs, Bertrand ^e   Meuleman, Eric ^f   O'Leary, Michael P ^g   Puppo, Paolo ^h   Robertson, Chris ^c   Giuliano, François ⁱ  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b KRANKENHAUS BARMHERZIGE BRÜDER   (Germany)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d ST GEORGE S HOSPITAL   (United Kingdom)

^e HÔPITAL TENON   (France)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h UNIVERSITY OF GENOA   (Italy)

ⁱ BICÊTRE HOSPITAL   (France)

Author keywords

LUTS; Prostatic hypertrophy; Sexual dysfunction

Indexed keywords

AGE DISTRIBUTION; COMORBIDITY; CONSULTATION; DEMOGRAPHY; EJACULATION DISORDER; ERECTILE DYSFUNCTION; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HEART DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MEDICAL ASSESSMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT INFORMATION; PATIENT SELECTION; POPULATION DENSITY; POSTAL MAIL; PROSTATE HYPERTROPHY; QUESTIONNAIRE; REVIEW; SAMPLE SIZE; SCORING SYSTEM; SENESCENCE; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; VALIDATION PROCESS;

AGED; AGED, 80 AND OVER; EJACULATION; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSTATIC HYPERPLASIA; QUESTIONNAIRES; UROLOGIC DISEASES;

EID: 4143133217     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. ABRAMS P. New words for old: lower urinary tract symptoms for "prostatism" [editorial]. Br. Med. J., 1994, 308, 929-930.
2. ABRAMS P. Managing lower urinary tract symptoms in older men. Br. Med. J., 1995, 310, 1113-1117.
3. JACOBSEN S.J., JACOBSON D.J., FIRMAN C.J., ROBERTS R.O., RHODES T., GUESS H.A. et al. Natural history of prostatism: risk factors for acute urinary retention. J. Urol., 1997, 158, 481-487.
4. SAGNIER P.P., McFARLANE G., TEILLAC P., BOTTO H., RICHARD F., BOYLE P. Impact of symptoms of prostatism on level of bother and quality of life of men in the French community. J. Urol., 1995, 153, 669-673.
5. NORMAN R.W., NICKEL J.C., FISH D., PICKETT S.N. "Prostate-related symptoms" in Canadian men 50 years of age or older: prevalence and relationships among symptoms. Br. J. Urol., 1994, 74, 542-550.
6. GARRAWAY W.M., RUSSELL E.B., LEE R.J., COLLINS G.N., McKelvie G.B., HEHIR M. et al. Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men. Br. J. Gen. Pract., 1993, 43, 318-321.
7. HUNTER D.J., McKEE m., BLACK N.A., SANDERSON C.F. Health status and quality of life of British men with lower urinary tract symptoms: results from the SF-36. Urology, 1995, 45, 962-971.
8. KASSABIAN V.S. Sexual function in patients treated for benign prostatic hyperplasia. Lancet, 2003, 361, 60-62.
9. McCONNELL J.D. Guidelines for diagnosis and management of benign prostatic hyperplasia. In: Kirby R., McConnell J., Fitzpatrick J., Roehrborn C;, Boyle P. editors. Textbook of Benign Prostatic Hyperplasia. Oxford. UK: Isis Medical Media Ltd., 1996, pp. 507-526.
10. FELDMAN H.A., GOLDSTEIN I., HATZCHRISTOU D.G., KRANE R.J., McKINLAY J.B. Impotence and its medical and psychosocial correlates: results of the Massuchusetts Male Aging Study. J. Urol., 1994, 151, 54-61.
11. FRANKEL S.J., DONOVAN J.L., PETERS T.I., ABRAMS P., DABHOIWALA N.F., OSAWA D. et al. Sexual dysfunction in men with lower urinary tract symptoms. J. Clin. Epidemiol., 1998, 51, 677-685.
12. BRAUN M., WASSMER G., KLOTZ T., REIFENRATH B., MATHERS M., ENGELMANN U. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int. J. Impot. Res., 2000, 12, 305-311.
13. LELIEFELD H.H., STOEVELAAR H.J., MCDONNELL J. Sexual function before and after various treatments for symptomatic benign prostatic hyperplasia. B.J.U. Int., 2002, 89, 208-213.
14. McFARLAND G.J., BOTTO H., SAGNIER PP., TEILLAC P., RICHARD F., BOYLE P. The relationship between sexual life and urinary condition in the French community. J. Clin. Epidemiol., 1996, 49, 1171-1176.
15. BLANKER M.H., BOHNEN A.M., GROENEVELD R.M.D., PRINS A., THOMAS S. et al. Correlated for erectile and ejaculatory dysfunction in older Dutch men: a community-based study. J. Am. Geriat. Soc., 2001, 49, 436-442.
16. VALE J., Benign prostatic hyperplasia and erectile dysfunction -is there a link? Curr. Med. Res. Opin., 2000, 16 (suppl. 1), 63-67.
17. CLIFFORD G.M., FARMER R.D. Medical therapy for benign prostatic hyperplasia: a review of the literature. Eur. Urol., 2000, 38, 2-19.
18. ARAI Y., AOKI Y., OKUBO K., MAEDA H., TERADA N., MATSUTA Y. et al. Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study. J. Urol., 2000, 164, 1206-1211.
19. WASSON J.H., REDA D.J., BRUSKEWITZ R.C., ELINSON J., KELLER A.M., HENDERSON W.J. for the Veterans Affaird Cooperative Study Group on Transurethral Resection of the Prostate. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. N. Engl. J. Med., 1995, 332, 75-79.
20. NUDELL D.M., CATTOLICA E.V. Transurethral prostatectomy: an update. AUA Update Series, 2000, 5, 34-39.
21. SAIRAM K., KULINSKAYA E., McNICHOLAS T.A., BOUSTEAD G.B., HANBURY D.C. Dildenafil influences lower urinary tract symptoms. B.J.U. Int., 2002, 90, 836-839.
22. BARRY M.J., FOWLER Jr. F.J., O'LEARY M.P., BRUSKEWITZ R.C., HOLTGREW H.L., MEBUST W.K. et al. For the Measurement Committee of the American Urological Association symptom index for benign prostatic hyperplasia. J. Urol., 1992, 148, 1549-1557.
23. HANSEN B.J., MORTENSEN S., MENSINK H.J., FLYGER H., RICHMANN M., HENDOLIN N. et al. Comparison of the Danish Prostatic Symptom Score with the International Prostatic Symptom Score, the Madsen-Iv ersen and Boyarsky symptom indexes. ALFECH Study Group. Br. J. Urol., 1998, 81, 36-41.
24. SCHOU J., HOLM N.R., MEYHOFF H.H. Sexual function in patients with symptomatic benign prostatic hyperplasia. Scand. J. Urol. Nephrol. Suppl. 1996, 179, 119-132.
25. ROSEN R.C., RILEY A., WAGNER G., OSTERLOH I.H., KIRKPATRICK J., MISHRA A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology, 1997, 49, 822-830.
26. DIOKNO A.C., BROWN M.B., HERZOG A.R. Sexual function in the elderly. Arch. Intern. Med., 1990, 150, 197-200.
27. LEPOR H. for the Tamsulosin Investigator Group. Phase III multi-center placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Urology, 1998, 51, 892-900.
28. NARAYAN P., LEPOR H. Long-term, open-label, phase III multicenter study of tamsulosin in benign prostatic hyperplasia. Urology, 2001, 57, 466-470.
29. STEERS W.D., CLEMOW D.B., PERSSON K., SHERER T.B., ANDERSSON K.E., TUTTLE J.B. The spontaneously hypertensive rat: insight into the pathogenesis of irritative symptoms in benign prostatic hyperplasia and young anxious males. Exp. Physiol., 1999, 84, 137-147.
30. CHANG S., HYPOLITE J.A., ZDERIC S.A., WEIN A.J., CHACKO S., DiSANTO M.E. Enhanced force generation by corpus cavernosum smooth muscle in rabbits with partial bladder outlet obstruction. J. Urol., 2002, 167, 2636-2644.
31. GOLDSTEIN I. The mutually reinforcing trial of depressive symptoms, cardiovascular disease and erectile dysfunction. Am. J. Cardiol., 2000, 86, 41F-5F.